Kodera Y - Search Results

1

In vitro chemosensitivity test to predict chemosensitivity for paclitaxel, using human gastric carcinoma tissues.

Kodera Y, Ito S, Fujiwara M, Mochizuki Y, Ohashi N, Ito Y, Nakayama G, Koike M, Yamamura Y, Nakao A. Kodera Y, et al. Int J Clin Oncol. 2006 Dec;11(6):449-53. doi: 10.1007/s10147-006-0618-x. Epub 2006 Dec 25. Int J Clin Oncol. 2006. PMID: 17180513

2

[A pilot study of combined chemotherapy using methotrexate (MTX), 5-fluorouracil (5-FU) and pirarubicin (THP) for advanced or recurrent gastric cancer].

Yamamura Y, Kodera Y, Kito T. Yamamura Y, et al. Among authors: kodera y. Gan To Kagaku Ryoho. 1995 Sep;22(10):1407-10. Gan To Kagaku Ryoho. 1995. PMID: 7668879 Clinical Trial. Japanese. No abstract available.

3

Establishment and characterization of human gastric and colonic xenograft lines resistant to CPT-11 (a new derivative of camptothecin).

Nagai S, Yamauchi M, Andoh T, Nishizawa M, Satta T, Kodera Y, Kondou K, Akiyama S, Ito K, Takagi H. Nagai S, et al. Among authors: kodera y. J Surg Oncol. 1995 Jun;59(2):116-24. doi: 10.1002/jso.2930590209. J Surg Oncol. 1995. PMID: 7776652

4

Expression of glutathione-S-transferases alpha and pi in gastric cancer: a correlation with cisplatin resistance.

Kodera Y, Isobe K, Yamauchi M, Kondo K, Akiyama S, Ito K, Nakashima I, Takagi H. Kodera Y, et al. Cancer Chemother Pharmacol. 1994;34(3):203-8. doi: 10.1007/BF00685078. Cancer Chemother Pharmacol. 1994. PMID: 8004752

5

Growth inhibition of human gastrointestinal cancer xenograft lines by treatment with CPT-11 and VP-16.

Nagai S, Yamauchi M, Satta T, Kodera Y, Kondou K, Akiyaya S, Ito K, Takagi H. Nagai S, et al. Among authors: kodera y. J Surg Oncol. 1993 Dec;54(4):211-5. doi: 10.1002/jso.2930540404. J Surg Oncol. 1993. PMID: 8255079

6

Incidence, diagnosis and significance of multiple gastric cancer.

Kodera Y, Yamamura Y, Torii A, Uesaka K, Hirai T, Yasui K, Morimoto T, Kato T, Kito T. Kodera Y, et al. Br J Surg. 1995 Nov;82(11):1540-3. doi: 10.1002/bjs.1800821127. Br J Surg. 1995. PMID: 8535813

7

Gastric remnant carcinoma after partial gastrectomy for benign and malignant gastric lesions.

Kodera Y, Yamamura Y, Torii A, Uesaka K, Hirai T, Yasui K, Morimoto T, Kato T, Kito T. Kodera Y, et al. J Am Coll Surg. 1996 Jan;182(1):1-6. J Am Coll Surg. 1996. PMID: 8542082

8

Preoperative intra-aortic ultrasonography to determine resectability in advanced oesophageal cancer.

Akiyama S, Kodera Y, Sekiguchi H, Fujiwara M, Sakámoto J, Kondo K, Ito K, Endo T, Takagi H. Akiyama S, et al. Among authors: kodera y. Br J Surg. 1995 Dec;82(12):1671-4. doi: 10.1002/bjs.1800821229. Br J Surg. 1995. PMID: 8548238 Clinical Trial.

9

The prognostic value of preoperative serum levels of CEA and CA19-9 in patients with gastric cancer.

Kodera Y, Yamamura Y, Torii A, Uesaka K, Hirai T, Yasui K, Morimoto T, Kato T, Kito T. Kodera Y, et al. Am J Gastroenterol. 1996 Jan;91(1):49-53. Am J Gastroenterol. 1996. PMID: 8561143

10

Feasibility study on protracted infusional 5-fluorouracil and consecutive low-dose cisplatin for advanced gastric cancer.

Kondo K, Murase M, Kodera Y, Akiyama S, Ito K, Yokoyama Y, Takagi H, Shirasaka T. Kondo K, et al. Among authors: kodera y. Oncology. 1996 Jan-Feb;53(1):64-7. doi: 10.1159/000227537. Oncology. 1996. PMID: 8570135 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,401 results

Search Page

Filters